Skip to main content
Fig. 4 | Journal of Experimental & Clinical Cancer Research

Fig. 4

From: Regorafenib enhances anti-PD1 immunotherapy efficacy in murine colorectal cancers and their combination prevents tumor regrowth

Fig. 4

REG and REG + aPD1 significantly reduce intratumoral macrophages and Treg cells. a Staining of frozen tumor sections for macrophages (F4/80) and quantification: mean values ± SD (n = 5–7) and individual values (dots). b Representative immunofluorescence images. Left panel: staining for F4/80 in green; right panel: staining for FoxP3 in red. Nuclei are DAPI stained (blue). Scale bars: 100 µm. c Quantification of staining for Treg cells (FoxP3) on day 14 with mean values ± SD (n = 6–7) and individual values (dots) and ratio of CD8+ cytotoxic T cells to Treg cells (see Supplementary Figure S3a for quantification for CD8+). Statistical significance (§day 7; #day 11; * day 14): */§/#p < 0.05; **/§§/##p < 0.01; ***/§§§/###p < 0.001; ****/§§§§/####p < 0.0001

Back to article page